Regeneron Pharmaceuticals News - REGN

Best deals to access real time data!
Big Cap Pro Monthly Subscription for only ~~$52.04~~
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB Monthly Subscription for only ~~$67.09~~
Level 1 Starter Monthly Subscription for only ~~$15.87~~
VAT not included

Company Name	Stock Ticker Symbol	Market	Type
Regeneron Pharmaceuticals Inc	REGN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	High Price	Low Price	Open Price	Close Price	Last Traded
	9.72	3.4%	295.87	297.64	286.68	288.75	286.15	19:59:46

more quote information »

Recent News

Date	Time	Source	Heading
9/20/2019	07:22	DJN	Regeneron, Sanofi Get Positive CHMP Opinion for Dupixent
9/20/2019	06:59	PRNUS	The Lancet Publishes Results from Two Positive Phase 3..
9/20/2019	06:44	PRNUS	CHMP Recommends Approval of Dupixent® (dupilumab) for Severe..
9/18/2019	06:59	PRNUS	Educational Campaign Helps Teens and Their Caregivers Tackle..
9/17/2019	07:00	PRNUS	Regeneron Debuts on Prestigious Dow Jones Sustainability..
9/12/2019	17:01	EDGAR	Statement of Changes in Beneficial Ownership (4)
8/28/2019	18:34	DJN	U.S. Federal Judge Rules for Sanofi, Regeneron in..
8/28/2019	16:56	PRNUS	U.S. District Court Invalidates Amgen Patent Claims..
8/15/2019	09:30	PRNUS	Regeneron Announces Upcoming Investor Conference..
8/14/2019	07:00	PRNUS	Regeneron Announces Positive Topline Results from Phase 3..
8/13/2019	07:00	PRNUS	FDA Approves EYLEA® (aflibercept) Injection Prefilled..
8/12/2019	15:16	DJN	Two Experimental Ebola Drugs Reduce Mortality Rate
8/12/2019	10:01	PRNUS	PALM Ebola Clinical Trial Stopped Early as Regeneron's..
8/06/2019	09:57	DJN	Regeneron, Sanofi: Dupixent Meets Main Endpoints in Children..
8/06/2019	09:22	DJN	Regeneron, Sanofi Get EC OK for Dupixent in Adolescents with..
8/06/2019	08:13	DJN	Regeneron Lowers Capital Expenditure Guidance, Changes Other..
8/06/2019	07:56	EDGAR	Quarterly Report (10-q)
8/06/2019	07:36	EDGAR	Current Report Filing (8-k)
8/06/2019	07:27	DJN	Regeneron's Profit Falls as Expenses Spike
8/06/2019	06:30	PRNUS	Regeneron Reports Second Quarter 2019 Financial and..
8/06/2019	01:04	PRNUS	Dupixent® (dupilumab) Showed Positive Topline Results in..
8/06/2019	00:59	PRNUS	Dupixent® (dupilumab) Approved by European Commission for..
7/18/2019	07:30	PRNUS	Regeneron Announces the 2019 Winners of the Regeneron Prize..
7/09/2019	17:37	DJN	Drugmakers Rise After Trump Pricing Rule Is Blocked
7/09/2019	13:58	DJN	Drugmakers Rise After Trump Pricing Rule Is Blocked
7/08/2019	09:30	PRNUS	Regeneron to Report Second Quarter 2019 Financial and..
7/01/2019	10:00	PRNUS	Libtayo® (cemiplimab) Approved for Advanced Cutaneous..
6/28/2019	08:03	DJN	Committee Recommends Approval for Dermatitis Treatment Be..
6/28/2019	06:59	PRNUS	CHMP Recommends Approval of Dupixent® (dupilumab) for..
6/26/2019	14:30	DJN	FDA Approves Sanofi, Regeneron Treatment for Chronic..
6/26/2019	13:30	PRNUS	FDA approves Dupixent® (dupilumab) for chronic..
6/26/2019	13:29	PRNUS	FDA Approves Dupixent® (dupilumab) for Chronic..
6/21/2019	06:39	DJN	Regeneron, Sanofi Report Positive Topline Phase 2 Asthma..
6/21/2019	00:59	PRNUS	Regeneron and Sanofi Announce Positive Topline Phase 2..
6/19/2019	17:21	EDGAR	Current Report Filing (8-k)
6/14/2019	07:56	DJN	Regeneron Says Early-Stage Results Positive for REGN1979 in..
6/14/2019	07:00	PRNUS	Regeneron CD20xCD3 Bispecific REGN1979 Shows Positive..
5/29/2019	16:19	EDGAR	Statement of Changes in Beneficial Ownership (4)
5/23/2019	09:30	PRNUS	Regeneron Announces Upcoming Investor Conference..
5/16/2019	07:00	PRNUS	Updated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable..
5/15/2019	16:05	EDGAR	Statement of Changes in Beneficial Ownership (4)
5/14/2019	10:47	EDGAR	Confidential Treatment Order (ct Order)
5/13/2019	16:19	PRNUS	FDA Approves EYLEA® (aflibercept) Injection for Diabetic..
5/13/2019	15:29	DJN	Regeneron Says FDA Approves Eylea Injection for All Diabetic..
5/13/2019	14:45	PRNUS	FDA Approves EYLEA® (aflibercept) Injection for Diabetic..
5/09/2019	16:52	EDGAR	Confidential Treatment Order (ct Order)
5/07/2019	17:01	EDGAR	Amended Current Report Filing (8-k/a)
5/07/2019	14:06	EDGAR	Confidential Treatment Order (ct Order)
5/07/2019	09:39	DJN	EU Approves Sanofi and Regeneron's Dupixent for Severe..
5/07/2019	08:59	PRNUS	Dupixent® (dupilumab) Approved for Severe Asthma by European..

See more news about this stock »

Regeneron Pharmaceuticals News - REGN

Recent News

REGN Historical - 1 Day

REGN Historical - 1 Year